Seres Therapeutics, Inc. Interest Income (Expense), Net
Seres Therapeutics, Inc. (MCRB) reported Interest Income (Expense), Net of $262.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2018-11-08
- Seres Therapeutics, Inc. interest income (expense), net for the quarter ending 2018-09-30 was $262.00K, a 30.87% decline year-over-year.
- Seres Therapeutics, Inc. interest income (expense), net for the quarter ending 2018-03-31 was $347.00K, a 16.59% decline year-over-year.
- Seres Therapeutics, Inc. interest income (expense), net for the quarter ending 2017-12-31 was $397.00K.
- Seres Therapeutics, Inc. interest income (expense), net for the quarter ending 2017-09-30 was $379.00K.
- Seres Therapeutics, Inc. interest income (expense), net for fiscal 2017 was $1.59M, a 26.19% increase from fiscal 2016.
- Seres Therapeutics, Inc. interest income (expense), net for fiscal 2016 was $1.26M, a 1418.07% increase from fiscal 2015.
- Seres Therapeutics, Inc. interest income (expense), net for fiscal 2015 was $83.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2018-09-30 | $262.00K 10-Q · filed 2018-11-08 | $958.00K 10-Q · filed 2018-11-08 | ||
| 2018-03-31 | $347.00K 10-Q · filed 2018-05-09 | $744.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.12M derived: sum of 3 quarters · filed 2018-11-08 | |
| 2017-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $776.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.59M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $379.00K 10-Q · filed 2018-11-08 | $1.19M 10-Q · filed 2018-11-08 | ||
| 2017-03-31 | $416.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $1.26M 10-K · filed 2018-03-08 | |||
| 2015-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $95.00K derived: sum of 2 quarters · filed 2018-03-08 | $100.00K derived: sum of 3 quarters · filed 2018-03-08 | $83.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | -$59.00K 10-Q · filed 2015-11-12 | -$54.00K derived: sum of 2 quarters · filed 2015-11-12 | -$71.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $5.00K 10-Q · filed 2015-08-10 | -$12.00K 10-Q · filed 2015-08-10 | ||
| 2014-09-30 | -$61.00K 10-Q · filed 2015-11-12 | -$117.00K derived: sum of 2 quarters · filed 2015-11-12 | -$154.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$56.00K 10-Q · filed 2015-08-10 | -$93.00K 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |